NCT01165008View on ClinicalTrials.gov

Anakinra in Myositis

PHASE2/PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2003

Study Completion Date

September 30, 2008

Conditions
PolymyositisDermatomyositisInclusion Body Myositis
Interventions
DRUG

Anakinra

Trial Locations (1)

17176

Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT01165008 - Anakinra in Myositis | Biotech Hunter | Biotech Hunter